Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal vaccination for primary prevention of cardiovascular events
ACTRN12615000536561Phase 3Active, not recruiting
- Sponsor
- University of Newcastle
- Start
- Feb 2016
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in cardiac morbidity, myocardial infarction (MI) and stroke comparing Pneumococcal polysaccharide vaccine with Placebo saline (2 arms). Primary endpoint: Composite major cardiovascular events. Started Feb 2016; status: active, not recruiting.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
cardiac morbiditymyocardial infarction (MI)stroke
Beyond the preview
Go deeper on ACTRN12615000536561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000536561.